Plague Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Streptomycin, Gentamycin, Other Antibiotics); End User (Hospitals, Clinics, Others) and Geography

Report Code: TIPRE00018325 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Plague is an infectious disease caused by bacterium Yersinia pestis. There are mainly three types of plague they are bubonic, pneumonic and septicemic. The symptoms of bubonic plague includes, swelling of lymph node, fever and weakness. In septicemic form the tissue turns black and die. Where in pneumonic form chest pain and shortness of breath is seen. The plague can be transmitted from handling of infected animal, flea bites, and droplets of infected person. The treatment of plague includes, vaccination and antibiotic therapy.

MARKET DYNAMICS

The key market drivers for Plague Market Includes, increasing prevalence of plague along with rising awareness about plague immunization across the globe. Moreover, rising adoption of companion animals is also expected to fuel market growth during forecast period. Whereas, strict regulatory approvals for drug and vaccine approval may restrain market growth during forecast period.

MARKET SCOPE

The "Plague Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Plague market with detailed market segmentation by Product and end user. The Plague Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Plague Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Plague Market is segmented on the basis of Product and end user. On the basis of product the market is segmented as, streptomycin, gentamycin, other antibiotics. And on the basis of end user the market is segmented as, hospitals, clinics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Plague Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Plague Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Plague Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Plague Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Plague Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Plague Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Plague market in the global market. Below mentioned is the list of few companies engaged in the Plague Market.

The report also includes the profiles of key players in Plague Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   iBio, Inc.
  •   DynPort Vaccine Company LLC.
  •   Bayer Healthcare
  •   Pfizer, Inc.
  •   AstraZeneca
  •   Astellas Pharma
  •   Basilea pharmaceutica AG
  •   Abbott
  •   Baxter International
  •   Biocon

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Plague Market - By Product
1.3.2 Plague Market - By End User
1.3.3 Plague Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PLAGUE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PLAGUE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PLAGUE MARKET - GLOBAL MARKET ANALYSIS
6.1. PLAGUE - GLOBAL MARKET OVERVIEW
6.2. PLAGUE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PLAGUE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. STREPTOMYCIN
7.3.1. Overview
7.3.2. Streptomycin Market Forecast and Analysis
7.4. GENTAMYCIN
7.4.1. Overview
7.4.2. Gentamycin Market Forecast and Analysis
7.5. OTHER ANTIBIOTICS
7.5.1. Overview
7.5.2. Other Antibiotics Market Forecast and Analysis
8. PLAGUE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. PLAGUE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Plague Market Overview
9.1.2 North America Plague Market Forecasts and Analysis
9.1.3 North America Plague Market Forecasts and Analysis - By Product
9.1.4 North America Plague Market Forecasts and Analysis - By End User
9.1.5 North America Plague Market Forecasts and Analysis - By Countries
9.1.5.1 United States Plague Market
9.1.5.1.1 United States Plague Market by Product
9.1.5.1.2 United States Plague Market by End User
9.1.5.2 Canada Plague Market
9.1.5.2.1 Canada Plague Market by Product
9.1.5.2.2 Canada Plague Market by End User
9.1.5.3 Mexico Plague Market
9.1.5.3.1 Mexico Plague Market by Product
9.1.5.3.2 Mexico Plague Market by End User
9.2. EUROPE
9.2.1 Europe Plague Market Overview
9.2.2 Europe Plague Market Forecasts and Analysis
9.2.3 Europe Plague Market Forecasts and Analysis - By Product
9.2.4 Europe Plague Market Forecasts and Analysis - By End User
9.2.5 Europe Plague Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Plague Market
9.2.5.1.1 Germany Plague Market by Product
9.2.5.1.2 Germany Plague Market by End User
9.2.5.2 France Plague Market
9.2.5.2.1 France Plague Market by Product
9.2.5.2.2 France Plague Market by End User
9.2.5.3 Italy Plague Market
9.2.5.3.1 Italy Plague Market by Product
9.2.5.3.2 Italy Plague Market by End User
9.2.5.4 Spain Plague Market
9.2.5.4.1 Spain Plague Market by Product
9.2.5.4.2 Spain Plague Market by End User
9.2.5.5 United Kingdom Plague Market
9.2.5.5.1 United Kingdom Plague Market by Product
9.2.5.5.2 United Kingdom Plague Market by End User
9.2.5.6 Rest of Europe Plague Market
9.2.5.6.1 Rest of Europe Plague Market by Product
9.2.5.6.2 Rest of Europe Plague Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Plague Market Overview
9.3.2 Asia-Pacific Plague Market Forecasts and Analysis
9.3.3 Asia-Pacific Plague Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Plague Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Plague Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Plague Market
9.3.5.1.1 Australia Plague Market by Product
9.3.5.1.2 Australia Plague Market by End User
9.3.5.2 China Plague Market
9.3.5.2.1 China Plague Market by Product
9.3.5.2.2 China Plague Market by End User
9.3.5.3 India Plague Market
9.3.5.3.1 India Plague Market by Product
9.3.5.3.2 India Plague Market by End User
9.3.5.4 Japan Plague Market
9.3.5.4.1 Japan Plague Market by Product
9.3.5.4.2 Japan Plague Market by End User
9.3.5.5 South Korea Plague Market
9.3.5.5.1 South Korea Plague Market by Product
9.3.5.5.2 South Korea Plague Market by End User
9.3.5.6 Rest of Asia-Pacific Plague Market
9.3.5.6.1 Rest of Asia-Pacific Plague Market by Product
9.3.5.6.2 Rest of Asia-Pacific Plague Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Plague Market Overview
9.4.2 Middle East and Africa Plague Market Forecasts and Analysis
9.4.3 Middle East and Africa Plague Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Plague Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Plague Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Plague Market
9.4.5.1.1 South Africa Plague Market by Product
9.4.5.1.2 South Africa Plague Market by End User
9.4.5.2 Saudi Arabia Plague Market
9.4.5.2.1 Saudi Arabia Plague Market by Product
9.4.5.2.2 Saudi Arabia Plague Market by End User
9.4.5.3 U.A.E Plague Market
9.4.5.3.1 U.A.E Plague Market by Product
9.4.5.3.2 U.A.E Plague Market by End User
9.4.5.4 Rest of Middle East and Africa Plague Market
9.4.5.4.1 Rest of Middle East and Africa Plague Market by Product
9.4.5.4.2 Rest of Middle East and Africa Plague Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Plague Market Overview
9.5.2 South and Central America Plague Market Forecasts and Analysis
9.5.3 South and Central America Plague Market Forecasts and Analysis - By Product
9.5.4 South and Central America Plague Market Forecasts and Analysis - By End User
9.5.5 South and Central America Plague Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Plague Market
9.5.5.1.1 Brazil Plague Market by Product
9.5.5.1.2 Brazil Plague Market by End User
9.5.5.2 Argentina Plague Market
9.5.5.2.1 Argentina Plague Market by Product
9.5.5.2.2 Argentina Plague Market by End User
9.5.5.3 Rest of South and Central America Plague Market
9.5.5.3.1 Rest of South and Central America Plague Market by Product
9.5.5.3.2 Rest of South and Central America Plague Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PLAGUE MARKET, KEY COMPANY PROFILES
11.1. IBIO, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. DYNPORT VACCINE COMPANY LLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAYER HEALTHCARE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTELLAS PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BASILEA PHARMACEUTICA AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ABBOTT
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAXTER INTERNATIONAL
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIOCON
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. iBio, Inc
2. DynPort Vaccine Company LLC
3. Bayer Healthcare
4. Pfizer, Inc
5. AstraZeneca
6. Astellas Pharma
7. Basilea Pharmaceutica AG
8. Abbott
9. Baxter International
10. Biocon
TIPRE00018325
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking